Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Desvenlafaxine succinate Monohydrate

Desvenlafaxine succinate Monohydrate

pharmaceutical raw materials
Desvenlafaxine succinate Monohydrate structure

Desvenlafaxine succinate Monohydrate 

structure
  • CAS No:

    386750-22-7

  • Formula:

    C20H31NO6

  • Chemical Name:

    Desvenlafaxine succinate Monohydrate

  • Synonyms:

    Desvenlafaxine succinate;4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol succinate hydrate;4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol succinate monohydrate;2-(1-Hydroxycyclohexyl)-2-(4-hydroxyphenyl)ethyl]dimethylammonium3-carboxypropanoatemonohydrate;Desvenlafaxine succinate monohydrate;Pristiq;Unii-zb22enf0xr;Desvenlafaxine (succinate hydrate)

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Desvenlafaxine succinate hydrate is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI).


Desvenlafaxine Succinate is a dual serotonin and norepinephrine reuptake inhibitor (SNRI) that was approved for the treatment of major depressive disorder (MDD) in the United States in 2008. In order to improve the efficacy and safety profile of venlafaxine, Wyeth discovered and developed one of the major metabolites of venlafaxine, namely the O-desmethyl metabolite (desvenlafaxine). Desvenlafaxine is also being developed for the treatment of moderate to severe vasomotor symptoms associated with menopause (i.e., hot flashes and night sweats) and is also in phase III clinical trials to study it’s effectiveness in treating fibromyalgia and neuropathic pain.


Desvenlafaxine succinate (Pristiq SR) is an extended-release tablet for oral administration that contains desvenlafaxine succinate, a structurally novel SNRI for treating MDD. Desvenlafaxine succinate is a white to off-white powder that is soluble in water. The solubility of Desvenlafaxine succinate is pH-dependent. Its octanol: aqueous system (at pH 7.0) partition coefficient is 0.21. Desvenlafaxine succinate (Pristiq SR) is available as a 50 mg extended-release tablet for oral administration. The 50 mg tablet consists of light pink, square (pyramid, one-sided), film-coated tablets debossed “W” over “50” on the flat side.

Desvenlafaxine succinate Monohydrate Basic Attributes

381.47

399.226

White to off-white

2922504500

Characteristics

119

2.66840

White crystalline powde

403.8ºC at 760 mmHg

193.2ºC

Store at +4°C

Store at +4°C

Safety Information

WGK 3

P201, P202, P260, P263, P264, P270, P273, P280, P281, P305+P351+P338, P308+P313, P337+P313, P391, P405, P501

H319

Desvenlafaxine succinate Monohydrate Use and Manufacturing

Antianxiety therapeutic

Recommended Suppliers of Desvenlafaxine succinate Monohydrate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.